Olivia Finney is currently the Director of Translational Sciences at BioNTech SE. Prior to this, Olivia held the position of Director of Oncology Research at 2seventy bio and bluebird bio. Olivia has extensive experience in leading correlative studies related to cellular immunotherapy trials for both blood and solid tumors. Olivia's background includes managing research laboratories, conducting immunological studies on malaria, and leading community-based studies on natural immunity to malaria. Olivia's educational background includes a BSc in Biology with a Year in Research from Imperial College London.
This person is not in any teams
This person is not in any offices